Febraury Issue of Pharma Marketing News Is Here
Pharma Marketing News Subscribe Today and get it FREE!CURRENT ISSUE: Vol. 4, No. 2: February 2005Links to summaries of individual articles below. ArticlesYou May...
Vioxx Redux
Just when you thought it was safe to go back into the water, Merck suggests that it may put Vioxx back on the market,...
Drug Safety: A Matter of Trust!
Those Canadians are at it again! Quick they are at being contrary to the U.S. This even extends to drug safety issues.As reported in...
3rd Annual Pharmaceutical Marketing and Sales Global Summit
The meeting carefully examines the changing marketing and sales models, posits strategic solutions for finding new opportunities in a fragmented market, how to implement new legislation, and addresses what executive marketing and sales executive management can do to thrive in the new environment.
Time for Pharma to Revamp Its Physician Marketing Strategy
Should pharma companies revamp their physician marketing strategies? Some idea of pharma's thinking on this topic is revealed in the emerging story of Pfizer's...
Pharma Sales Force Bloat and the Mythical Man-Month
A myth long believed at pharma companies --as well as at other companies -- is that by by hiring more salespeople you can proportionately...
Pfizer to Slash 30% of its Sales & Marketing Staff
Pfizer Inc. may slash its 38,000-member sales and marketing staff by as much as 30%, or 11,400 employees.
Pfizer Inc., the world's biggest drugmaker, may...
CBI’s Summit on Post-Marketing Studies
Featured Conference CBI's Summit on Post-Marketing Studies February 7 - 8, 2005 ...
It’s the land of success!
Big Pharma had a plan.
It designed a trial for a COX-2 drug and it ran.
Yet it wasn’t enough to get pain low.
What's this?
We’re still...
Times They Are A-Changing?
Now that market forces are starting to turn negative, have we reached a point where the bloat (inefficiency) is unsustainable? Or are threats of layoffs just a ploy to sustain stock market value?
